Last reviewed · How we verify
Topical AmphiMatrix
Topical AmphiMatrix is a topical matrix formulation that combines multiple active ingredients to provide sustained release of therapeutic agents.
Topical AmphiMatrix is a topical matrix formulation that combines multiple active ingredients to provide sustained release of therapeutic agents. Used for Treatment of psoriasis.
At a glance
| Generic name | Topical AmphiMatrix |
|---|---|
| Sponsor | MediQuest Therapeutics |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action is not well-documented, but it is believed to work by slowly releasing active ingredients into the skin, providing prolonged therapeutic effects. This can be beneficial for conditions that require consistent treatment over an extended period.
Approved indications
- Treatment of psoriasis
Common side effects
- Skin irritation
Key clinical trials
- A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon (PHASE3)
- Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis (PHASE2)
- Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical AmphiMatrix CI brief — competitive landscape report
- Topical AmphiMatrix updates RSS · CI watch RSS
- MediQuest Therapeutics portfolio CI